MedPath

UNIVERSITY OF ARIZONA

UNIVERSITY OF ARIZONA logo
🇺🇸United States
Ownership
Private
Established
1885-01-01
Employees
10K
Market Cap
-
Website
http://www.arizona.edu

Octapharma's PANZYGA Shows Mixed Results in Phase 3 PANS Trial, Achieves Significant Secondary Endpoint

Octapharma's phase 3 trial of PANZYGA for pediatric acute-onset neuropsychiatric syndrome (PANS) missed its primary endpoint of reducing obsessive-compulsive symptoms measured by CY-BOCS score.

Ketamine Shows Promise in Restoring Motor Control in Parkinson's Patients with Dyskinesia

Researchers have discovered that levodopa-induced dyskinesia in Parkinson's patients involves a functional disconnection of the motor cortex from movement control.

© Copyright 2025. All Rights Reserved by MedPath